Artesunate for Injection is now available for the initial treatment of severe malaria in adult and pediatric patients. Artesunate and its metabolite dihydroartemisinin (DHA) are both active against ...
The Food and Drug Administration (FDA) has approved Artesunate for Injection (Amivas) for the initial treatment of severe malaria in adult and pediatric patients. The approval was based on data from ...
Indicated for the initial treatment of severe malaria in adult and pediatric patients, Artesunate for Injection received marketing approval by the U.S. Food and Drug Administration (FDA) on May 26, ...
Artesunate and its metabolite DHA are both active against the blood-stage asexual parasites and gametocytes of Plasmodium species including the chloroquine resistant strains. Artesunate for Injection ...
The FDA has approved Artesunate for Injection (Amivas) for the initial treatment of severe malaria in adult and pediatric patients. The Food and Drug Administration (FDA) has approved Artesunate for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results